...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: TNBC Competition

in response to

TNBC Competition

Toinv

posted on Feb 20, 2023 03:05PM

A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer (TNBC) Phase 2

https://clinicaltrials.gov/ct2/show/NCT03901469

Now Recruiting

Last Update Posted Feb 2, 2023

Estimated Primary Completion date Nov 2023

Estimated Completion Date May 2024

Koo

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply